Last week, the Southern District Court of Ohio heard the first oral arguments from the U.S. Chamber of Commerce (CoC, the Chamber) and the U.S. Department of Justice (DOJ). The Chamber requested an injunction of the Medicare negotiation program before October 1, which is the deadline for companies to sign an agreement to participate in...
Humana has filed suit against the Centers for Medicare and Medicaid Services (CMS) for a rule announced earlier this year that would allow the government to recoup overpayments from insurers based on extrapolated audits. Also, Novartis has challenged the Biden administration over the Medicare Drug Price Negotiation rule.
Studies have...
The Biden administration released its list of 10 drugs for direct price negotiations with manufacturers. The highly anticipated list is the most recent step in enacting a part of the Inflation Reduction Act (IRA) of 2022. The drugs listed are largely treatments related to Type 2 diabetes, blood thinning, arthritis and cancer...
Last week, the Fifth Circuit Court of Appeals in New Orleans issued a decision that restricts the use of mifepristone, a medication that is used in abortion. The U.S. Department of Justice, which is defending the Food and Drug Administration in the case, said that it would appeal the decision to the Supreme Court.
The three-judge...
The Biden administration released revised guidance for the Medicare drug price negotiation program late last week in response to the mounting lawsuits against the policy required by the Inflation Reduction Act (IRA) of 2022.
Drugmakers Merck and Bristol Myers Squibb, as well as industry representatives like the U.S. Chamber of...
Pharmaceutical industry advocacy organizations including the Pharmaceutical Research and Manufacturers of America (PhRMA) and a third drug manufacturer have sued the federal government over the provision of the Inflation Reduction Act (IRA) that allowed for Medicare drug price negotiation for select pharmaceuticals.
Pharmaceutical...
President Joe Biden signed the Inflation Reduction Act (IRA) on Tuesday, a $430 billion bill that includes a number of health-related programs that the Biden administration has touted as high-priority since the 2020 presidential campaign.
The bill includes an extension for federal health insurance subsidies and allows the government...National News
Last week President Joe Biden called on U.S. lawmakers to enact legislation aimed at lowering drug prices, including allowing Medicare to negotiate drug prices and imposing penalties on drugmakers that hike prices faster than inflation.
Biden said that U.S. prescription drug costs were higher than any other nation in the world by two to...CMS Rules
The Centers for Medicare & Medicaid Services (CMS) released a proposed rule last Wednesday that delays the implementation of a Trump-era rule which would incentivize the use of value-based drug pricing agreements for the Medicaid program. The original version of the regulation was finalized in December 2021, but the Biden...Arizona News
Health care enrollment under the Affordable Care Act (ACA) is continuing to climb in Arizona and across the country during the special enrollment period (SEP) as benchmark premiums also continue to decline.
According to ABC15, the Centers for Medicare & Medicaid Services (CMS) logged 17,081 Arizonans have selected plans during the...National News
This week, President Donald Trump signed an executive order designed to cut prescription drug prices by tying prices to international prices. Two months ago, the President signed several executive orders that also intended to lower drug prices and constrict Medicare rebates.
The Sunday order says the Medicare program should pay...Arizona News
The pharmaceutical companies on Capitol Hill rarely get the short-end of the stick, so it shouldn't come as a surprise that the industry is lobbying for a provision to block the increase of the percentage of drug costs they must cover under Medicare.
Lawmakers are now considering to add measures that would ease the burden of drug...
